Literature DB >> 12359224

Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester.

Nicole C Kaneider1, Angela Djanani, Reiner Fischer-Colbrie, Christian J Wiedermann.   

Abstract

Syndecan-4 participates in focal adhesion by non-G protein-dependent activation of protein kinase C. Ligation of syndecan-4 with antithrombin elicits pertussis toxin-sensitive chemotaxis of leukocytes. As activation of protein kinase C stimulates release of sphingosine-1-phosphate, a chemoattracting G protein-coupled receptor agonist, we studied directional migration of leukocytes in response to phorbol myristate acetate (PMA), a direct activator of protein kinase C. Human peripheral blood neutrophils, monocytes, and lymphocytes were purified and tested for chemotactic migration in micropore filter assays in response to PMA. Dose-dependent stimulation of migration was seen only when leukocytes were exposed to concentration gradients of PMA; in the absence of such a gradient, inhibition of random migration was induced. Dimethylsphingosine inhibited PMA-induced leukocyte chemotaxis, indicating that activation of sphingosine kinase for enhanced production of sphingosine-1-phosphate mediates the chemotactic response to PMA. Pertussis toxin abrogated the chemotactic response to PMA, suggesting involvement of G protein-coupled sphingosine-1-phosphate receptor. Dimethylsphingosine also inhibited leukocyte chemotaxis toward antithrombin, indicating that similar mechanisms may be involved upon syndecan-4 ligation. Data show that protein kinase C-dependent activation of sphingosine kinase may play a central role in leukocyte chemotaxis toward non-G protein-coupled receptor agonists.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359224     DOI: 10.1016/s0006-291x(02)02304-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Sphingosine kinase-dependent migration of immature dendritic cells in response to neurotoxic prion protein fragment.

Authors:  Nicole C Kaneider; Arthur Kaser; Stefan Dunzendorfer; Herbert Tilg; Christian J Wiedermann
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 2.  Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer.

Authors:  Dmitri Pchejetski; Torsten Böhler; Justin Stebbing; Jonathan Waxman
Journal:  Nat Rev Urol       Date:  2011-09-13       Impact factor: 14.432

3.  A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis.

Authors:  Ashley J Snider; Toshihiko Kawamori; Sarah G Bradshaw; K Alexa Orr; Gary S Gilkeson; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2008-09-24       Impact factor: 5.191

4.  Documentation and localization of force-mediated filamin A domain perturbations in moving cells.

Authors:  Fumihiko Nakamura; Mia Song; John H Hartwig; Thomas P Stossel
Journal:  Nat Commun       Date:  2014-08-14       Impact factor: 14.919

Review 5.  The emerging role of FTY720 (Fingolimod) in cancer treatment.

Authors:  Christopher White; Heba Alshaker; Colin Cooper; Matthias Winkler; Dmitri Pchejetski
Journal:  Oncotarget       Date:  2016-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.